Economy

FY2017 EPS Estimates for Alexion Pharmaceuticals, Inc. (ALXN) Reduced by Analyst

The firm has "Neutral" rating by Credit Suisse given on Wednesday, January 20. Finally, TheStreet upgraded shares of Alexion Pharmaceuticals from a "c" rating to a "b-" rating in a report on Friday, July 14th. The firm has "Buy" rating given on Wednesday, November 23 by Seaport Global. The stock presently has a consensus rating of "Buy" and a consensus price target of $154.56. On Friday, September 15 the stock rating was maintained by BMO Capital Markets with "Hold". The rating was maintained by Barclays Capital with "Equal-Weight" on Thursday, February 4.

06/23/2017 - Alexion Pharmaceuticals, Inc. had its "neutral" rating reiterated by analysts at Robert W. Baird. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Geneva Advisors LLC now owns 11,408 shares of the biopharmaceutical company's stock worth $1,388,000 after purchasing an additional 82 shares during the last quarter. The Lmm Llc holds 450,725 shares with $54.84 million value, up from 358,700 last quarter. Kazazian Asset Management Llc who had been investing in Alexion Pharmaceuticals Inc for a number of months, seems to be bullish on the $31.52 billion market cap company.

Alexion Pharmaceuticals (NASDAQ:ALXN) traded up 0.61% on Monday, reaching $119.61. About 1.01 million shares traded. The original version of this story can be accessed at https://www.dispatchtribunal.com/2017/10/19/fy2017-eps-estimates-for-alexion-pharmaceuticals-inc-alxn-reduced-by-analyst.html. It has underperformed by 34.82% the S&P500. On average, analysts expect Alexion Pharmaceuticals to post $5.60 EPS for the current fiscal year and $7.13 EPS for the next fiscal year. BidaskClub upgraded shares of Alexion Pharmaceuticals from a "hold" rating to a "buy" rating in a research note on Tuesday, July 25th. Therefore 78% are positive. SunTrust Banks, Inc. restated a "buy" rating and set a $165.00 price objective on shares of Alexion Pharmaceuticals in a research note on Friday, July 14th. The firm has "Buy" rating by Citigroup given on Tuesday, September 20. On Thursday, August 3 the stock rating was maintained by BMO Capital Markets with "Hold". FBR Capital initiated Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) in a research note released on Monday morning. The rating was downgraded by BTIG Research on Thursday, January 7 to "Neutral". UBS AG restated a "buy" rating and issued a $142.00 price objective (up from $140.00) on shares of Alexion Pharmaceuticals in a report on Monday, June 26th. Alexion Pharmaceuticals has a 52-week low of $96.18 and a 52-week high of $149.34. (NASDAQ:ALXN) on Friday, April 29 to "Outperform" rating.

Municipal Employees Retirement System of MI increased its holdings in shares of Alexion Pharmaceuticals by 1.2% during the first quarter. Its up 0.23, from 1.14 in 2017Q1. Credit Agricole S A increased its holdings in shares of Alexion Pharmaceuticals by 10.4% during the first quarter. 72 funds opened positions while 203 raised stakes. Moreover, Barrett Asset Mngmt Ltd has 0% invested in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) for 22,622 shares. Following the completion of the sale, the executive vice president now owns 26,704 shares in the company, valued at approximately $3,738,560.

Cincinnati Specialty Underwriters Insurance Co holds 6.6% of its portfolio in Polaris Industries Inc. for 78,500 shares. Finally, Bridgewater Associates LP bought a new position in Alexion Pharmaceuticals in the first quarter valued at approximately $1,621,000. Municipal Employees Retirement System of MI now owns 8,770 shares of the biopharmaceutical company's stock worth $1,063,000 after purchasing an additional 100 shares during the period. Bridger Management Ltd, a New York-based fund reported 206,006 shares. Artal Gru has invested 0.21% in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Oppenheimer Asset Mngmt holds 0.07% or 21,235 shares. Pictet Cie (Europe) accumulated 10,195 shares. First Republic Investment Management Inc. increased its position in Alexion Pharmaceuticals by 3.0% in the first quarter. Moreover, Tarbox Family Office has 0% invested in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Jefferies Limited Liability Co owns 20,994 shares or 0.02% of their U.S. portfolio.

Since June 14, 2017, it had 4 buys, and 1 sale for $235.75 million activity. The shares were sold at an average price of $145.44, for a total value of $636,300.00. COUGHLIN CHRISTOPHER J bought 2,000 shares worth $234,200. 10,000 shares valued at $1.17M were bought by HANTSON LUDWIG on Wednesday, June 14. Raymond James Trust N.A. now owns 4,268 shares of the biopharmaceutical company's stock valued at $499,000 after buying an additional 643 shares during the last quarter.

06/08/2017 - Alexion Pharmaceuticals, Inc. had its "buy" rating reiterated by analysts at Goldman Sachs. (ALXN) Misled Shareholders ..." with publication date: "September 26, 2017. The stock has a market cap of $31.26 billion, a P/E ratio of 60.73 and a beta of 1.39. More interesting news about Alexion Pharmaceuticals, Inc.

Tourbillon Capital Partners Lp increased Synchrony Finl (NYSE:SYF) stake by 5.12 million shares to 5.60 million valued at $167.04 million in 2017Q2.

Alexion Pharmaceuticals, Inc.is a biopharmaceutical company. Seven Bridges Advisors LLC increased its position in Alexion Pharmaceuticals by 2.1% in the second quarter.



Like this

loading...
loading...

Latest


20 October 2017
MGIC Investment Corporation (MTG) Price Target Raised to $16.00 at MKM Partners
Janus Henderson Group PLC acquired a new stake in shares of MGIC Investment Corporation in the second quarter worth $45,117,000. The company was maintained on Thursday, January 21 by M Partners. (NYSE: MTG ) on Tuesday, August 25 with "Buy" rating.

20 October 2017
MCMC and police investigating data breach
The technology portal believed the data breach had taken place from 2012 to 2015. Screengrab of the report that was removed from Lowyat.net.

20 October 2017
Strs Ohio Sells 309244 Shares of Pfizer, Inc. (NYSE:PFE)
BidaskClub upgraded shares of Pfizer from a "strong sell" rating to a "sell" rating in a research report on Friday, June 23rd. Institutional investors own 68.98% of the company's stock. 17,224 are owned by Horizon Invs Limited Liability Corp.

20 October 2017
BB&T Corporation (BBT) Holdings Boosted by WINTON GROUP Ltd
This repurchase authorization authorizes the insurance provider to buy up to 5.2% of its stock through open market purchases. In the most recent session, the stock price hovered around $0.36 (0.77%) between intraday high and intraday low.

20 October 2017
Julia Louis-Dreyfus completes second round of chemo
She revealed her diagnosis on September 28, 2017 and she's been doing everything possible to fight since. "Chemo #2: finito. Now, nearly a month later, the actress took to Instagram to post that she had finished her second round of chemotherapy.

20 October 2017
Are Insiders Shedding Shares of Calpine Corporation (NYSE:CPN)?
BidaskClub raised shares of Calpine Corporation from a "sell" rating to a "hold" rating in a research note on Tuesday, June 27th. The stock is now moving above its 20-Day Simple Moving Average of 0.59% with a 50-Day Simple Moving Average of 1.85 percent.

20 October 2017
Twenty-First Century Fox, Inc. (FOX) Investment Increased by National Pension Service
Comparatively, Twenty-First Century Fox has a beta of 1.28, suggesting that its stock price is 28% more volatile than the S&P 500. Exane Derivatives raised its stake in Twenty-First Century Fox, Inc . shares by 2.2% as reported in a filing on 10/20/2017.

20 October 2017
Is Brad Pitt in a relationship with Angelina Jolie's lookalike?
For more exclusive celebrity news, pick up the latest issue of In Touch, on newsstands now! He can't get her out of his mind. " Brad plans on coaching Ella for the show".

20 October 2017
Blue Buffalo Pet Products, Inc. (BUFF) Stake Increased by Vanguard Group Inc
The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website . Note, this compares with a consensus analyst forecast of 0.25 in earnings per share for its next fiscal quarterly report.

20 October 2017
Now, fatwa against Muslim women from posting images on social media
The Deoband is said to have announced that Muslim women should not post their pictures on Facebook , WhatsApp and Twitter. Darul Uloom Deoband considers the act of posting photographs in social media as "un-Islamic".